Real-world study on the treatment of stage III colorectal cancer

Phase 1

• Conditions: Colorectal cancer

• Registration Number: ITMCTR2000003662
• Lead Sponsor: onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Meet the diagnostic criteria for stage III colorectal cancer, with clear pathological evidence.
2. Surgery and chemotherapy have been completed.
3. Between 18-75 years old (including 18 and 75 years old), there is no restriction on men and women.
4. KPS >= 60 points, estimated to be able to survive more than 6 months.
5. Bone marrow, heart, liver, and kidney functions are basically normal.

Exclusion Criteria

1. Cases of malignant lymphoma or stromal tumor.
2. At the same time combined with other malignant tumors.
3. People with mental disorders.
4. Women who are pregnant or breastfeeding.
5. Under chemotherapy.
6. People with severe heart, liver, and kidney disease and dysfunction.
7. With severe complications (such as gastrointestinal obstruction, bleeding).
8. Those who are participating in other drug trials.
9. Allergy or discomfort to the study drug.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Metastasis site;Transfer time;

Secondary Outcome Measures

Name	Time	Method
Quality of Life;Tumor markers;TCM clinical syndrome score;Liver function;Blood routine;Immune Function;kidney function;